# Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies

> **NCT01594502** · — · COMPLETED · sponsor: **University of Illinois at Chicago** · enrollment: 139 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Dutasteride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01594502
- **Lead sponsor:** University of Illinois at Chicago
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2015-11
- **Final completion:** 2016-07
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2020-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01594502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01594502, "Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01594502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*